Market Closed -
Other stock markets
|
After market 05:29:04 pm | |||
132 USD | +0.15% | 131.7 | -0.16% |
03:30pm | Robert Davis, Merck CEO: Another obesity drug? | MT |
03:02pm | Merck: new indication approved for Keytruda in Europe | CF |
- Stock
- Equities
- Stock Merck & Co., Inc. - Nyse
- News Merck & Co., Inc.